BMS 986470
Alternative Names: BMS-986470Latest Information Update: 01 Aug 2024
At a glance
- Originator Bristol-Myers Squibb
- Class Antianaemics; Small molecules
- Mechanism of Action Apoptosis stimulants; CRBN protein modulators; Fetal haemoglobin expression modulators; Ubiquitin protein ligase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Sickle cell anaemia